688765 禾元生物-U
已收盘 09-18 15:00:01
资讯
新帖
简况
每周股票复盘：禾元生物（688765）奥福民®上市推动营收增43.77%
证券之星 · 09-13
每周股票复盘：禾元生物（688765）奥福民®上市推动营收增43.77%
禾元生物（688765）披露2026年度持续督导半年度跟踪报告，9月10日股价下跌3.74%
证券之星 · 09-10
禾元生物（688765）披露2026年度持续督导半年度跟踪报告，9月10日股价下跌3.74%
每周股票复盘：禾元生物（688765）股东户数降10.06%，中报营收增43.77%
证券之星 · 08-30
每周股票复盘：禾元生物（688765）股东户数降10.06%，中报营收增43.77%
禾元生物（688765）2026年中报简析：营收上升亏损收窄，存货明显上升
证券之星 · 08-28
禾元生物（688765）2026年中报简析：营收上升亏损收窄，存货明显上升
禾元生物（688765）披露2026年半年度报告，8月26日股价上涨2.69%
证券之星 · 08-26
禾元生物（688765）披露2026年半年度报告，8月26日股价上涨2.69%
禾元生物(688765)6月30日股东户数1.51万户，较上期减少10.06%
证券之星 · 08-26
禾元生物(688765)6月30日股东户数1.51万户，较上期减少10.06%
每周股票复盘：禾元生物（688765）收盘跌15%登龙虎榜
证券之星 · 08-02
每周股票复盘：禾元生物（688765）收盘跌15%登龙虎榜
禾元生物（688765）2569.08万股限售股将于7月28日解禁，占总股本7.19%
证券之星 · 07-28
禾元生物（688765）2569.08万股限售股将于7月28日解禁，占总股本7.19%
每周股票复盘：禾元生物（688765）7.19%限售股7月28日上市
证券之星 · 07-26
每周股票复盘：禾元生物（688765）7.19%限售股7月28日上市
禾元生物（688765）披露首次公开发行网下配售部分限售股上市流通公告，7月20日股价上涨1.54%
证券之星 · 07-20
禾元生物（688765）披露首次公开发行网下配售部分限售股上市流通公告，7月20日股价上涨1.54%
每周股票复盘：禾元生物（688765）将参加2026年投资者接待日活动
证券之星 · 07-05
每周股票复盘：禾元生物（688765）将参加2026年投资者接待日活动
禾元生物（688765）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨4.59%
证券之星 · 07-01
禾元生物（688765）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨4.59%
异动快报：禾元生物-U（688765）6月29日14点34分触及涨停板
证券之星 · 06-29
异动快报：禾元生物-U（688765）6月29日14点34分触及涨停板
每周股票复盘：禾元生物（688765）开立募资专户补充流动资金
证券之星 · 06-28
每周股票复盘：禾元生物（688765）开立募资专户补充流动资金
股市必读：禾元生物（688765）6月25日董秘有最新回复
证券之星 · 06-26
股市必读：禾元生物（688765）6月25日董秘有最新回复
禾元生物（688765）发布关于开立募集资金临时补充流动资金专项账户并签订监管协议的公告，6月24日股价下跌0.68%
证券之星 · 06-24
禾元生物（688765）发布关于开立募集资金临时补充流动资金专项账户并签订监管协议的公告，6月24日股价下跌0.68%
每周股票复盘：禾元生物（688765）完成工商变更登记
证券之星 · 06-07
每周股票复盘：禾元生物（688765）完成工商变更登记
股市必读：禾元生物（688765）今年截至6月1日累计跌幅已超25%
证券之星 · 06-02
股市必读：禾元生物（688765）今年截至6月1日累计跌幅已超25%
禾元生物（688765）披露持股5%以上股东部分股份质押公告，5月19日股价下跌0.91%
证券之星 · 05-19
禾元生物（688765）披露持股5%以上股东部分股份质押公告，5月19日股价下跌0.91%
每周股票复盘：禾元生物（688765）奥福民®上市推动营收增89.80%
证券之星 · 05-17
每周股票复盘：禾元生物（688765）奥福民®上市推动营收增89.80%
加载更多
公司概况
公司名称：
武汉禾元生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2025-10-28
主营业务：
武汉禾元生物科技股份有限公司的主营业务是运用水稻胚乳细胞重组蛋白表达技术平台进行植物源人血清白蛋白等产品的研发、生产及销售。公司的主要产品是药品、药用辅料、科研试剂。
发行价格：
29.06
{"stockData":{"symbol":"688765","market":"SH","secType":"STK","nameCN":"禾元生物-U","latestPrice":37.75,"timestamp":1789714801000,"preClose":35.9,"halted":0,"volume":5154038,"delay":0,"changeRate":0.0515,"floatShares":71970800,"shares":358000000,"eps":-0.3865,"marketStatus":"已收盘","change":1.85,"latestTime":"09-18 15:00:01","open":36.22,"high":39.5,"low":36.22,"amount":196000000,"amplitude":0.0914,"askPrice":37.76,"askSize":2,"bidPrice":37.75,"bidSize":35,"shortable":0,"etf":0,"ttmEps":-0.3865,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":5,"adr":0,"adjPreClose":35.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789695000000,1789702200000],[1789707600000,1789714800000]],"highLimit":39.49,"lowLimit":32.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":357500000,"isCdr":false,"pbRate":4.75,"roa":"--","roe":"--","epsLYR":-0.555,"committee":-0.840717,"marketValue":13496000000,"turnoverRate":0.0716,"status":0,"afterMarket":{"amount":24537.5,"volume":650,"close":37.75,"buyVolume":1750,"sellVolume":0,"time":1789716837746,"indexStatus":"已收盘 09-18 15:30:00","preClose":35.9},"floatMarketCap":2717000000},"requestUrl":"/m/hq/s/688765","defaultTab":"news","newsList":[{"id":"2667500403","title":"每周股票复盘：禾元生物（688765）奥福民®上市推动营收增43.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500403","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500403?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:48","pubTimestamp":1789242494,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，禾元生物报收于35.42元，较上周的36.6元下跌3.22%。本周，禾元生物9月8日盘中最高价报39.34元。国泰海通证券股份有限公司发布的持续督导半年度跟踪报告显示，禾元生物2026年上半年核心产品奥福民已获批上市，系国内首个重组人白蛋白药品。报告期内公司营业收入同比增长43.77%，亏损同比收窄，研发费用为5238.52万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666914595","title":"禾元生物（688765）披露2026年度持续督导半年度跟踪报告，9月10日股价下跌3.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666914595","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666914595?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:23","pubTimestamp":1789050198,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，禾元生物报收于36.24元，较前一交易日下跌3.74%，最新总市值为129.56亿元。该股当日开盘37.6元，最高37.61元，最低36.09元，成交额达9170.42万元，换手率为3.49%。近日，国泰海通证券股份有限公司发布《关于武汉禾元生物科技股份有限公司2026年度持续督导半年度跟踪报告》。公告显示，禾元生物2026年上半年持续督导报告显示，公司核心产品奥福民已获批上市，为国内首个重组人白蛋白药品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663102760","title":"每周股票复盘：禾元生物（688765）股东户数降10.06%，中报营收增43.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663102760","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663102760?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:10","pubTimestamp":1788034221,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，禾元生物报收于38.5元，较上周的37.27元上涨3.3%。本周，禾元生物8月28日盘中最高价报39.96元。业绩披露要点财务报告禾元生物2026年中报显示，上半年度公司主营收入1827.42万元，同比上升43.77%；归母净利润-6275.65万元，同比上升23.12%；扣非净利润-8855.91万元，同比上升2.18%。公司公告汇总2026年半年度报告摘要截至报告期末，禾元生物总资产为3,850,586,479.54元，较上年度末增长3.99%；归属于上市公司股东的净资产为2,843,715,723.66元，较上年度末减少1.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662903987","title":"禾元生物（688765）2026年中报简析：营收上升亏损收窄，存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662903987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662903987?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:21","pubTimestamp":1787869300,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期禾元生物发布2026年中报。截至本报告期末，公司营业总收入1827.42万元，同比上升43.77%，归母净利润-6275.65万元，同比上升23.12%。本报告期禾元生物存货明显上升，存货同比增幅达200.36%。本文数据来源于禾元生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662710305","title":"禾元生物（688765）披露2026年半年度报告，8月26日股价上涨2.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662710305","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662710305?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:11","pubTimestamp":1787753512,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，禾元生物报收于37.02元，较前一交易日上涨2.69%，最新总市值为132.35亿元。该股当日开盘36.15元，最高39.59元，最低36.15元，成交额达2.43亿元，换手率为8.84%。近日，武汉禾元生物科技股份有限公司披露《2026年半年度报告》。公告显示，截至报告期末，公司总资产为3,850,586,479.54元，较上年度末增长3.99%；归属于上市公司股东的净资产为2,843,715,723.66元，较上年度末减少1.87%。公司前10名股东中，杨代常持股比例最高，为11.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600052217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662794947","title":"禾元生物(688765)6月30日股东户数1.51万户，较上期减少10.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662794947?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:38","pubTimestamp":1787737094,"startTime":"0","endTime":"0","summary":"证券之星消息，近日禾元生物披露，截至2026年6月30日公司股东户数为1.51万户，较3月31日减少1690.0户，减幅为10.06%。在生物制品行业个股中，禾元生物股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.53万户。从股价来看，2026年3月31日至2026年6月30日，禾元生物区间跌幅为20.66%，在此期间股东户数减少1690.0户，减幅为10.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600039625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316142","title":"每周股票复盘：禾元生物（688765）收盘跌15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316142","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316142?lang=zh_cn&edition=full","pubTime":"2026-08-02 02:09","pubTimestamp":1785607752,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，禾元生物报收于33.8元，较上周的45.0元下跌24.89%。本周，禾元生物7月27日盘中最高价报46.57元。7月30日盘中最低价报32.61元，股价触及近一年最低点。禾元生物当前最新总市值120.83亿元，在生物制品板块市值排名22/51，在两市A股市值排名1465/5202。本周关注点来自交易信息汇总：禾元生物因日收盘价格跌幅达15%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654029756","title":"禾元生物（688765）2569.08万股限售股将于7月28日解禁，占总股本7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654029756","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654029756?lang=zh_cn&edition=full","pubTime":"2026-07-28 08:15","pubTimestamp":1785197725,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，禾元生物于7月28日将有2569.08万股限售股份解禁，为公司首发机构配售股份，占公司总股本7.19%。最近一年内，该股累计解禁530.13万股，占总股本的1.48%。本次解禁后，公司还有2.86亿股限售股份，占总股本79.87%。禾元生物主营业务：植物分子医药的研发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800006506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654527400","title":"每周股票复盘：禾元生物（688765）7.19%限售股7月28日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2654527400","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654527400?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:57","pubTimestamp":1785002233,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，禾元生物报收于45.0元，较上周的51.25元下跌12.2%。公司公告汇总武汉禾元生物科技股份有限公司首次公开发行网下配售限售股共计25,690,807股，占公司总股本的7.19%，限售期为自股票上市之日起9个月，将于2026年7月28日起上市流通。本次变动后，公司有限售条件流通股减少至285,529,154股，无限售条件流通股增加至71,970,846股，总股本不变。保荐机构国泰海通证券股份有限公司对本次限售股上市流通事项无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652211705","title":"禾元生物（688765）披露首次公开发行网下配售部分限售股上市流通公告，7月20日股价上涨1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652211705","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652211705?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:35","pubTimestamp":1784558113,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，禾元生物报收于52.04元，较前一交易日上涨1.54%，最新总市值为186.04亿元。近日，禾元生物发布《关于首次公开发行网下配售部分限售股上市流通公告》。公告显示，公司首次公开发行网下配售部分限售股将于2026年7月28日上市流通，本次上市流通数量为25,690,807股，占公司总股本的7.1862%。本次限售股上市流通后，相关股东持有的限售股份将全部解除限售。保荐机构国泰海通证券股份有限公司对本次限售股上市流通事项无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649942536","title":"每周股票复盘：禾元生物（688765）将参加2026年投资者接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2649942536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649942536?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:39","pubTimestamp":1783190350,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，禾元生物报收于52.62元，较上周的42.96元上涨22.49%。本周，禾元生物7月2日盘中最高价报54.8元。本周共计1次涨停收盘，无跌停收盘情况。禾元生物当前最新总市值188.12亿元，在生物制品板块市值排名13/50，在两市A股市值排名1153/5203。本周关注点公司公告汇总：禾元生物将参加2026年7月9日举办的投资者集体接待日活动暨2025年度业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648418265","title":"禾元生物（688765）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨4.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648418265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648418265?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:27","pubTimestamp":1782916032,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，禾元生物报收于53.34元，较前一交易日上涨4.59%，最新总市值为190.69亿元。该股当日开盘52.02元，最高54.07元，最低49.7元，成交额达2.53亿元，换手率为10.45%。近日，禾元生物发布《关于参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会的公告》。投资者可通过“全景路演”网站、微信公众号“全景财经”或下载全景路演APP参与。公司高管将在活动中就2025年度业绩、公司治理、发展战略、经营状况等与投资者进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647732638","title":"异动快报：禾元生物-U（688765）6月29日14点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647732638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647732638?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:40","pubTimestamp":1782715234,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，14点34分禾元生物-U（688765）触及涨停板。其所属行业生物制品目前上涨。领涨股为三生国健。该股为创新药，医药概念热股，当日创新药概念上涨6.68%，医药概念上涨4.81%。6月26日的资金流向数据方面，主力资金净流出1062.41万元，占总成交额16.08%，游资资金净流入457.32万元，占总成交额6.92%，散户资金净流入605.09万元，占总成交额9.16%。近5日资金流向一览见下表：禾元生物-U主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646331321","title":"每周股票复盘：禾元生物（688765）开立募资专户补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2646331321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646331321?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:42","pubTimestamp":1782585731,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，禾元生物报收于42.96元，较上周的46.19元下跌6.99%。本周，禾元生物6月23日盘中最高价报47.6元。专户仅用于补充流动资金项目，不得他用。关于开立募集资金临时补充流动资金专项账户并签订监管协议的公告武汉禾元生物科技股份有限公司于2026年4月24日召开第四届董事会第十二次会议，审议通过使用不超过10,000万元闲置募集资金临时补充流动资金，有效期自董事会审议通过之日起不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646388519","title":"股市必读：禾元生物（688765）6月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2646388519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646388519?lang=zh_cn&edition=full","pubTime":"2026-06-26 02:32","pubTimestamp":1782412332,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，禾元生物报收于45.18元，下跌2.63%，换手率4.27%，成交量1.98万手，成交额8819.05万元。公司公告汇总：禾元生物两家全资子公司于6月25日完成开立募集资金专户并签署四方监管协议，专户余额截至6月2日均为0万元。关于开立募集资金临时补充流动资金专项账户并签订监管协议的公告武汉禾元生物科技股份有限公司使用不超过10,000万元闲置募集资金临时补充流动资金事项，已于2026年4月24日经第四届董事会第十二次会议审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600001235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645581199","title":"禾元生物（688765）发布关于开立募集资金临时补充流动资金专项账户并签订监管协议的公告，6月24日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645581199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645581199?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:39","pubTimestamp":1782311954,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，禾元生物报收于46.4元，较前一交易日下跌0.68%，最新总市值为165.88亿元。公告显示，公司于2026年4月24日召开第四届董事会第十二次会议，审议通过使用不超过10,000万元闲置募集资金临时补充流动资金，有效期自董事会审议通过之日起不超过12个月。公司已开立募集资金临时补充流动资金专项账户，并与保荐机构国泰海通证券股份有限公司、开户银行签署监管协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400044208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641601127","title":"每周股票复盘：禾元生物（688765）完成工商变更登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2641601127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641601127?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:29","pubTimestamp":1780770549,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，禾元生物报收于47.87元，较上周的51.66元下跌7.34%。本周，禾元生物6月1日盘中最高价报52.64元。本周关注点公司公告汇总：禾元生物完成经营范围变更及工商登记，并换发营业执照。公司公告汇总武汉禾元生物科技股份有限公司于2026年4月24日和5月19日分别召开第四届董事会第十二次会议及2025年年度股东会，审议通过变更经营范围、修订《公司章程》并授权办理工商变更登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640698599","title":"股市必读：禾元生物（688765）今年截至6月1日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640698599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640698599?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:02","pubTimestamp":1780336935,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，禾元生物报收于51.11元，下跌1.06%，换手率2.98%，成交量1.38万手，成交额7092.44万元。当日关注点来自交易信息汇总：禾元生物股价连续5日下跌，当日主力资金净流出506.13万元，占总成交额7.14%。交易信息汇总股价提醒6月1日禾元生物收盘报51.11元，跌1.06%，当日成交7092.44万元。该股已连续5日下跌，当年累计跌幅26.03%。前10个交易日中，主力资金累计净流出5201.4万元，股价累计下跌7.17%；融资余额累计减少974.33万元，融券余量累计增加0股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636283730","title":"禾元生物（688765）披露持股5%以上股东部分股份质押公告，5月19日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636283730","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636283730?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:06","pubTimestamp":1779185204,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，禾元生物报收于56.38元，较前一交易日下跌0.91%，最新总市值为201.56亿元。公司于近日披露《关于持股5%以上股东部分股份质押的公告》。公告显示，截至公告披露日，武汉禾元生物科技股份有限公司股东上海同盛永盈企业管理中心持有公司股份20,084,400股，占公司总股本的5.62%。本次质押股份6,340,000股，占其持股总数的31.57%，占公司总股本的1.77%。已质押股份中限售股份数量为18,070,000股，无冻结情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061768","title":"每周股票复盘：禾元生物（688765）奥福民®上市推动营收增89.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636061768?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:38","pubTimestamp":1778956691,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，禾元生物报收于57.28元，较上周的58.02元下跌1.28%。本周，禾元生物5月13日盘中最高价报62.5元。2025年7月，公司首个创新药奥福民获批上市，系国内首个重组人白蛋白药品。报告期内，公司营业收入同比增长89.80%，主要得益于奥福民的销售增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688765"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789813790161,"stockEarnings":[{"period":"1week","weight":0.0658},{"period":"1month","weight":0.0264},{"period":"3month","weight":-0.1827},{"period":"6month","weight":-0.4506},{"period":"1year","weight":0.299},{"period":"ytd","weight":-0.4538}],"compareEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0045},{"period":"3month","weight":-0.0437},{"period":"6month","weight":-0.0114},{"period":"1year","weight":0.0209},{"period":"ytd","weight":-0.0144}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉禾元生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15107人(较上一季度减少10.06%)","perCapita":"4764股","listingDate":"2025-10-28","address":"湖北省武汉市江夏区武汉东湖新技术开发区神墩五路268号","registeredCapital":"35750万元","survey":" 武汉禾元生物科技股份有限公司的主营业务是运用水稻胚乳细胞重组蛋白表达技术平台进行植物源人血清白蛋白等产品的研发、生产及销售。公司的主要产品是药品、药用辅料、科研试剂。","listedPrice":29.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"禾元生物-U(688765)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供禾元生物-U(688765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"禾元生物-U,688765,禾元生物-U股票,禾元生物-U股票老虎,禾元生物-U股票老虎国际,禾元生物-U行情,禾元生物-U股票行情,禾元生物-U股价,禾元生物-U股市,禾元生物-U股票价格,禾元生物-U股票交易,禾元生物-U股票购买,禾元生物-U股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"禾元生物-U(688765)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供禾元生物-U(688765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}